|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating activities: | ||
| Net income | ||
| Adjustments to reconcile consolidated net income to net cash provided by operating activities: | ||
| Depreciation, depletion and amortization | ||
| Cash surrender value increase in excess of premiums paid | ||
| Goodwill impairment | ||
| Impairment charges on assets other than goodwill | ||
| Impairment charges | ||
| Share-based compensation expense | ||
| Deferred income tax benefit | ||
| Pension and other postretirement funding more than cost | ||
| Other | ||
| Change in operating assets and liabilities, net of acquisitions and divestitures: | ||
| Accounts receivable | ||
| Inventories | ||
| Other assets | ||
| Accounts payable | ||
| Income taxes | ||
| Accrued liabilities and other | ||
| Net cash provided by operating activities | ||
| Investing activities: | ||
| Capital expenditures | ||
| Cash paid for purchase of businesses, net of cash acquired | ||
| Proceeds from corporate owned life insurance | ||
| Proceeds from sale of property, plant and equipment | ||
| Deferred consideration paid | ||
| Other | ||
| Net cash used for investing activities | ||
| Financing activities: | ||
| Additions to debt | ||
| Repayments of debt | ||
| Debt issuance costs | ||
| Changes in commercial paper, net | ||
| Other debt (repayments) additions, net | ||
| Repayments of finance lease liabilities | ||
| Tax paid in connection with shares withheld from employees | ||
| Purchases of treasury stock | ||
| Share buyback | ||
| Cash dividends paid to shareholders | ||
| Other | ||
| Net cash (used for) provided by financing activities | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| Increase (decrease) in cash and cash equivalents | ||
| Cash and cash equivalents at January 1 | ||
| Cash and cash equivalents at December 31 |
Loading...
